Children's Hospital Colorado — Aurora, Colorado

Public research footprint of Children's Hospital Colorado, compiled from the ClinicalTrials.gov public registry.

977

Registered studies

383

Active

195

Recruiting now

473

Completed

Stopped or withdrawn

Most-studied conditions

Botryoid-Type Embryonal Rhabdomyosarcoma · B Acute Lymphoblastic Leukemia · Spindle Cell Rhabdomyosarcoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT06177067 — Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients… (Recruiting)
NCT04320888 — Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic… (Active Not Recruiting)
NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Children's Hospital Colorado?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.